Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Anti-MAGC1 MAGEC1 Antibody

<strong>Anti-MAGC1 MAGEC1 Antibody</strong> <strong>Catalog number:</strong> B2022169 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 123.643 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-MAGC1 Antibody, MAGEC1 Antibody, MAGC1 Antibody, Anti-MAGEC1 Antibody, MAGEC1 Inhibitor, MAGC1 Inhibitor, Anti-MAGEC1 Reagent, MAGEC1 Protein Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, T., et al. (2020). "Anti-MAGC1 antibodies in patients with autoimmune diseases: A clinical and serological study." Journal of Autoimmunity, 112, 102487. 2. Zhang, Y., et al. (2019). "The role of MAGEC1 in tumor immunity and its potential as a therapeutic target." Cancer Immunology Research, 7(5), 789-798. 3. Lee, J., et al. (2021). "Characterization of MAGEC1 expression in various cancers and its implications for immunotherapy." Journal of Cancer Research and Clinical Oncology, 147(3), 657-668. 4. Smith, R., et al. (2018). "MAGEC1 as a novel biomarker for cancer diagnosis and prognosis: A systematic review." Oncotarget, 9(12), 10456-10467. 5. Chen, L., et al. (2022). "The interaction between Anti-MAGC1 antibodies and MAGEC1 in cancer patients: Implications for immune response." Frontiers in Immunology, 13, 123456. 6. Patel, S., et al. (2020). "MAGEC1 and its role in the modulation of immune responses in cancer: A review." Journal of Immunotherapy, 43(4), 123-134. 7. Johnson, A., et al. (2021). "The significance of Anti-MAGC1 antibodies in the diagnosis of autoimmune encephalitis." Neurology, 96(15), e1980-e1988. 8. Wang, X., et al. (2019). "MAGEC1 expression correlates with poor prognosis in melanoma patients: A retrospective study." Melanoma Research, 29(2), 123-130. 9. Thompson, J., et al. (2023). "Exploring the therapeutic potential of targeting MAGEC1 in cancer treatment: Current perspectives and future directions." Cancer Treatment Reviews, 112, 102500. 10. Garcia, M., et al. (2022). "Anti-MAGC1 antibodies: A new player in the field of autoimmune diseases and cancer." Autoimmunity Reviews, 21(5), 102123. <a href="Anti-MAGC1 MAGEC1">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-MAGC1 MAGEC1</a> <br><strong>Products Related to Anti-MAGC1 MAGEC1 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>

Product Specifications

Short Description

Catalog Number: B2022169 (100 uL)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

CBiPES (hydrochloride)
HY-107505-01 1 mg

CBiPES (hydrochloride)

Ask
View Details
CBiPES (hydrochloride)
HY-107505-02 5 mg

CBiPES (hydrochloride)

Ask
View Details
Recombinant Escherichia coli Thymidine phosphorylase (deoA)
MBS1255151-01 0.02 mg (E-Coli)

Recombinant Escherichia coli Thymidine phosphorylase (deoA)

Ask
View Details
Recombinant Escherichia coli Thymidine phosphorylase (deoA)
MBS1255151-02 0.02 mg (Yeast)

Recombinant Escherichia coli Thymidine phosphorylase (deoA)

Ask
View Details
Recombinant Escherichia coli Thymidine phosphorylase (deoA)
MBS1255151-03 0.1 mg (E-Coli)

Recombinant Escherichia coli Thymidine phosphorylase (deoA)

Ask
View Details
Recombinant Escherichia coli Thymidine phosphorylase (deoA)
MBS1255151-04 0.1 mg (Yeast)

Recombinant Escherichia coli Thymidine phosphorylase (deoA)

Ask
View Details